52
Participants
Start Date
April 30, 2011
Primary Completion Date
March 31, 2012
HQK-1001
HQK-1001 tablets, once daily for daily 26 weeks
University of North Carolina at Chapel Hill - Comprehensive Sickle Cell Program, Chapel Hill
Georgia Health Sciences University - Adult SIckle Cell Center, Augusta
University of Miami Miller School of Medicine - Dept of Pediatrics, Miami
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Illinois at Chicago - Dept of Pediatrics, Chicago
LSU Health Sciences Center - Feist Weiller Cancer Center, Shreveport
Children's Hospital and Research Center - Oakland, Oakland
Tufts Medical Center, Boston
Univerisity of Texas Southwestern Medical Center at Dallas - Pediatric Hematology Oncology, Dallas
The Hospital for Sick Children, Toronto
University Health Network Toronto General Hospital, Toronto
Abu El Reesh Pediatric University Hospital, Cairo
University of the West Indies - Sickle Cell Unit, Mona
American University of Beirut Medical Center, Beirut
Rafik Hariri University Hospital, Beirut
Chronic Care Center, Hazmiyeh
Lead Sponsor
HemaQuest Pharmaceuticals Inc.
INDUSTRY